Product Information

LISDEXAMFETAMINE 40 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $2.6298 per EA under NDC 00781247801. Its NADAC has been published 44 times since Oct 22, 2025.

FDA first approved this application on Jul 26, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 40 MG CAPSULE

Lisdexamfetamine dimesylate
$2.6298per EA
DEA Schedule CII

Strength

40 mg/1

Manufacturer

Sandoz Inc.

NDC

00781247801

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202836

FDA Approved

7/26/2024

TE Code

AB

On Market Since

9/16/2025

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has been published 44 times since Oct 22, 2025, and over the history we have for it it has declined 20.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6298 per EA
All-time high$3.2967 (Nov 12, 2025)
All-time low$2.6298 (Aug 19, 2026)
52-week high$3.2967
52-week low$2.6298
Median price$3.0646
Average price$3.0388
Largest weekly change-4.1% (Apr 22, 2026)
Weeks tracked44
Tracking sinceOct 22, 2025

Price History

1W

-3.5%

1M

-6.6%

3M

-10.0%

6M

-15.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-20.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 40 MG CAPSULE, manufactured by Sandoz Inc., is $2.6298 per EA (NDC 00781247801), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has declined 20.2%. It has been tracked across 44 weekly CMS publications since Oct 22, 2025.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 40 MG CAPSULE?

Since Oct 22, 2025, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has ranged from a low of $2.6298 (Aug 19, 2026) to a high of $3.2967 (Nov 12, 2025), with a median of $3.0646 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 40 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 40 MG CAPSULE?

LISDEXAMFETAMINE 40 MG CAPSULE (NDC 00781247801) is labeled by Sandoz Inc., and CMS classifies it as a generic product.